BPA Call HT942523A0016-HT942524F0123
Award Date 3/12/24
Potential Completion Date 3/28/24
Potential Value $45K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency has awarded a firm-fixed-price Blanket Purchase Agreement (BPA) call to Verogen, Inc., a biotechnology research company specializing in forensic genomics and DNA sequencing. This $81,521.36 contract provides the agency with ForenSeq mitochondrial DNA (mtDNA) whole genome sequencing kits and consumables to support its genomic sequencing initiatives. Verogen holds a $7,433,000 single-award BPA with the Defense Health Agency, awarded in November 2023, to supply a range...
- This is a firm fixed price contract awarded by the Defense Health Agency to Verogen, Inc., a biotechnology research company that specializes in forensic genomics and DNA sequencing. The contract has a potential value of $235,984.48 and does not have a set-aside designation. Through this contract, Verogen will provide the Defense Health Agency with various products and services related to next-generation DNA sequencing, including MiSeq FGx sequencing systems, ForenSeq reagent kits, sequencing...
- The Defense Health Agency awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Verogen, Inc., a biotechnology company specializing in forensic genomics and DNA sequencing. The $199,858.60 contract is for the provision of NEXTSEQ 500/550 MID sequencing systems, reagents, consumables, and technical support services to support the agency's genomic sequencing programs. Verogen has previously provided similar products and services to federal agencies such as the FBI, Army Criminal...
- This firm fixed-price contract award to Verogen, Inc. by the Defense Health Agency is a BPA call order valued at $225,050.22. It does not have a set-aside designation. The contract is for the procurement of MiSeq RGT KIT V3 (150) sequencing reagents and consumables to support the agency's genomic sequencing programs. Verogen is a biotechnology company that specializes in forensic genomics and DNA sequencing, and has previously provided similar products and services to federal agencies such as...
- The Defense Health Agency (DHA) has awarded a firm-fixed-price Blanket Purchase Agreement (BPA) call to Verogen, Inc. for the provision of testing reagents and consumables to support the agency's genomic sequencing initiatives. The contract, valued at $46,967.19, is for the delivery of products such as MiSeq reagent kits, NextSeq systems, and ForenSeq kits. This BPA, which has no set-aside designation, was originally awarded to Verogen in November 2023 and runs through October 2028. Verogen, a...
- This contract was awarded by the Defense Health Agency to Verogen, Inc., a biotechnology company specializing in forensic genomics and DNA sequencing. The $153,135.25 Blanket Purchase Agreement (BPA) Call is for the delivery of MiSeq Reagent Kits, a type of next-generation sequencing consumable. The contract is a firm fixed-price vehicle without a small business set-aside designation. Verogen has previously supported the Defense Health Agency, Federal Bureau of Investigation, U.S. Army...
- This is a federal contract award to Verogen, Inc., a biotechnology company specializing in forensic genomics and DNA sequencing. The award, valued at $93,198.80, was issued by the Defense Health Agency (DHA) and provides for the procurement of Illumina reagents and consumables through a Blanket Purchase Agreement (BPA) call. The contract does not have a small business set-aside designation. Verogen, as the prime contractor, will supply the DHA with its MiSeq FGx sequencing systems, ForenSeq...
- This federal contract award was made by the Defense Health Agency to Verogen, Inc., a biotechnology company specializing in forensic genomics and DNA sequencing. The $82,836.24 contract, awarded on November 22, 2019, is a Blanket Purchase Agreement (BPA) call for the procurement of MiSeq RGT KIT V2 reagents and consumables. The contract has a firm fixed price and an ultimate completion date of November 27, 2019. Verogen, the prime contractor, has supported various federal agencies such as the...
- This is a firm fixed-price contract awarded by the Defense Health Agency to Verogen, Inc., a biotechnology research company specializing in forensic genomics and DNA sequencing. The contract, valued at $413,414.01, is for the provision of MiSeQ RGT V3 sequencing systems, reagents, consumables, and technical support services. The contract is a Blanket Purchase Agreement (BPA) call, which allows the agency to procure standardized laboratory supplies to support its genomic sequencing programs....
- This federal contract award was issued by the Defense Health Agency to Verogen, Inc., a biotechnology research company specializing in forensic genomics and DNA sequencing. The $92,962.80 Firm Fixed Price contract is for the delivery of MiSeq Reagent Kits (150 Cycle) under a Blanket Purchase Agreement call. The contract has no set-aside designation and was awarded on December 13, 2018 with a completion date of January 4, 2019. Verogen is an experienced prime contractor and subcontractor that has...
- HT942523A0016Blanket Purchase Agreement
- HT942523A0016-HT942524F0123BPA Call
This contract award to Verogen, Inc., a biotechnology research company specializing in forensic genomics and DNA sequencing, was made by the Defense Health Agency. The $45,483.03 firm-fixed-price contract provides for the delivery of ForenSeq Kintelligence KT reagents, which are used in next-generation DNA sequencing systems. This is a Blanket Purchase Agreement (BPA) call, part of a larger $7,433,000 single-award BPA that Verogen holds with the Defense Health Agency. The BPA allows the agency to efficiently procure standardized laboratory supplies needed to support its ongoing genomic sequencing initiatives. This contract award does not have a small business set-aside designation.
Generated 9/17/24, 9:25 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $45.5k | 3/12/24 |